Blog
RSS FeedPosted by Michael Wonder on 31 Oct 2021
Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme
1 November 2021 - In the event of a medicine shortage, a provision under section 19A of the Therapeutic Goods ...
Posted by Michael Wonder on 31 Oct 2021
New and amended PBS listings to help thousands of Australians
30 October 2021 - From 1 November 2021, Australians with a respiratory illness, early onset puberty and blood cancer will have ...
Posted by Michael Wonder on 29 Oct 2021
Public Summary Documents – July 2021 PBAC meeting
29 October 2021 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the July 2021 PBAC ...
Posted by Michael Wonder on 29 Oct 2021
PBS arrangements for tocilizumab shortage – 1 November 2021
29 October 2021 - In response to the shortages of multiple presentations of tocilizumab (Actemra) products, the PBAC has recommended temporary ...
Posted by Michael Wonder on 28 Oct 2021
Mallinckrodt and Terumo Blood and Cell Technologies announce positive recommendations in Australia for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos Cellex photopheresis system for chronic graft versus host disease in adults
28 October 2021 - In a dual review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement ...
Posted by Michael Wonder on 27 Oct 2021
Audrey Ashman’s bone treatment for rare genetic disease known as XLH denied government subsidy
24 October 2021 - Audrey Ashman loves to ballet dance and plays with her brothers — but she needs a special ...
Posted by Michael Wonder on 24 Oct 2021
DoH publishes yet another revised version of the agenda for the November 2021 PBAC meeting
25 October 2021 - We make this version number 10. ...
Posted by Michael Wonder on 24 Oct 2021
Breast cancer treatment expanded on the Pharmaceutical Benefits Scheme
24 October 2021 - The Morrison Government is helping improve access to an important treatment for Australians battling a form of ...
Posted by Michael Wonder on 21 Oct 2021
Tasmania's Pharmacy Guild wants antiviral COVID-19 pills available in all pharmacies
20 October 2021 - Tasmania has a stockpile of two different antiviral pill products which are sitting in the Royal ...
Posted by Michael Wonder on 18 Oct 2021
Australia secures additional COVID-19 treatments
17 October 2021 - The Australian Government has secured access to two additional COVID-19 treatments to support the National Plan to ...
Posted by Michael Wonder on 17 Oct 2021
Recommendations made by the PBAC – September 2021 intracycle meeting
15 October 2021 - First PBAC recommendation for a new gene therapy. ...
Posted by Michael Wonder on 15 Oct 2021
Recommendations made between March 2021 and November 2021 PBAC meetings
15 October 2021 - Recommendations made by the PBAC between the March 2021 and November 2021 have been published. ...
Posted by Michael Wonder on 15 Oct 2021
Updates to the procedure guidance for listing medicines on the PBS
15 October 2021 - The Department has updated Section 5.8 New brand of existing pharmaceutical item submissions (not requiring PBAC consideration) ...
Posted by Michael Wonder on 12 Oct 2021
DoH revises agenda ahead of new month's PBAC meeting
12 October 2021 - One minor change. ...
Posted by Michael Wonder on 11 Oct 2021
Review of the National Medicines Policy
11 October 2021 - The call for submissions closed on Friday 8 October 2021 and a total of 107 submissions have ...